*Pharmaceutical and Medicine Manufacturing (NAICS 3254); Medical and Diagnostic Laboratories (NAICS 62151)*Manufacturing
As a global leader in blood component, therapeutic apheresis and cellular technologies, we believe in the potential of blood and cells to do even more for patients than they do today. This belief inspires our innovation and strengthens our collaboration with customers in more than 130 countries.
Advancing Health Care Worldwide
Working together with our customers, we can make safer, higher-quality transfusions available to more people. We can bring even more treatment options to patients through advanced blood therapies. We develop and provide blood component and cellular technologies with the combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. We offer products in the areas of apheresis collections, therapeutic apheresis, cell therapy systems, and whole blood processing and pathogen reduction technologies. Our products include automated blood collection systems, information systems, data collection systems, apheresis systems, cell processors, cell separation systems, pathogen reduction technology systems, whole blood processing systems, cell expansion systems, sterile tubing welders, blood bags, tube sealing devices.
The Terumo Blood and Cell Technologies Vietnam facility with more than 1,600 employees is state-of-the-art. It incorporates the best of our global manufacturing design and processes, allowing us to better serve customer needs for incremental capacity, a robust business continuity infrastructure and the highest level of quality.